癌症治療基因組學市場規模、佔有率和成長分析：按產品/服務、技術、應用、癌症類型和地區分類－2026-2033年產業預測

2024 年全球癌症治療基因組學市場價值為 210.6 億美元，預計到 2033 年將從 2025 年的 244.4 億美元成長至 803.4 億美元，預測期（2026-2033 年）的複合年成長率為 16.04%。

隨著基因組分析在腫瘤學中日益重要，全球癌症治療基因組學市場正在蓬勃發展。次世代定序、生物資訊平台和伴隨診斷等技術對於識別具有治療價值的突變和實現個人化治療至關重要，從而提高生存率並減少治療副作用。從單基因檢測到多基因檢測的轉變是一項重大進步，因為保險報銷獎勵正日益推動分子檢測的普及，從而降低無效治療帶來的成本。人工智慧驅動的基因組學利用龐大的分子資料集和機器學習技術，進一步增強了這一領域的實力，能夠根據個體基因譜制定個人化的治療方案。這些先進技術和策略性投資的協同作用正在促進生物技術、製藥和醫療資訊技術領域的夥伴關係，推動個人化癌症治療的發展和效率的提升。

癌症治療基因組學市場的全球促進因素

隨著精準醫療在腫瘤學領域的應用日益廣泛，基因組分析正迅速融入常規醫療實踐，使醫療專業人員能夠根據個別腫瘤的特定DNA特徵制定個人化治療方案。這種個人化方法不僅改善了患者的治療效果，也激勵醫療機構採用先進的基因組技術。因此，製藥公司正在加速研發標靶治療，保險公司也日益認知到避免無效治療所帶來的長期成本節約。這一趨勢推動了對全面基因測序服務及相關數據分析的需求不斷成長，最終促進了市場發展。

全球癌症治療基因體學市場面臨的限制因素

全球癌症治療基因體學市場面臨許多限制因素，主要源自於複雜且區域差異顯著的監管環境。這種複雜性導致核准時間長短不一、資料隱私要求各異以及基因組檢測合規標準不一，最終阻礙了市場發展。企業必須巧妙應對這種獨特的法規環境，這可能導致產品上市延遲和研發成本飆升。這種情況會阻礙中小企業進入市場，並給潛在投資者帶來不確定性。此外，繁瑣的文件要求和持續的審計會分散企業研發和商業化方面的寶貴資源，進一步阻礙市場擴張。

全球基因組學市場在癌症治療領域的趨勢

全球癌症治療基因組學市場正呈現出整合式臨床工作流程的顯著趨勢，基因組學檢查室、電子健康記錄和腫瘤平台之間的協同作用顯著提升了患者體驗。這種協作加速了資料交換，大幅縮短了處理時間，並使多學科團隊能夠快速回應可操作的基因突變。對治療反應的持續監測有助於制定更精準的治療策略，從而改善臨床療效並提高營運效率。隨著醫療保健系統互通性重要性的日益凸顯，用於有效整合基因組分析結果並將其應用於常規癌症治療的基礎設施投資也在不斷增加，這為創新療法的出現鋪平了道路。

目錄

介紹

• 調查目的
• 市場定義和範圍

調查方法

• 研究過程
• 二級資料和一級資料的方法
• 市場規模估算方法

執行摘要

• 全球市場展望
• 市場主要亮點
• 細分市場概覽
• 競爭環境概述

市場動態及展望

• 總體經濟指標
• 促進者和機會
• 抑制因素和挑戰
• 供給面趨勢
• 需求面趨勢
• 波特的分析和影響

關鍵市場分析

• 關鍵成功因素
• 影響市場的因素
• 主要投資機會
• 生態系測繪
• 2025年市場魅力指數
• PESTLE分析
• 監理情勢

全球基因組學市場在癌症治療領域的規模：按產品和服務分類。

• 裝置
• 消耗品
• 服務

全球基因組學市場在癌症治療領域的規模：按技術分類

• 次世代定序
• 聚合酵素鏈鎖反應
• 微陣列
• 其他

全球癌症治療基因組學市場規模：按應用領域分類。

• 診斷
• 個人化醫療
• 藥物發現
• 調查

全球基因組學市場規模在癌症治療領域的應用：以癌症類型分類

• 乳癌
• 肺癌
• 結腸癌
• 其他

全球基因組學在癌症治療領域的市場規模：按地區分類

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太國家
• 拉丁美洲
  • 墨西哥
  • 巴西
  • 其他拉丁美洲國家
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲國家

競爭資訊

• 前五大公司對比
• 主要公司2025年的市場定位
• 主要市場公司採取的策略
• 近期市場趨勢
• 企業市場占有率分析，2025 年
• 主要公司的完整公司簡介
  • 公司詳情
  • 產品系列分析
  • 按細分市場進行企業市佔率分析
  • 銷售收入年比比較（2023-2025 年）

主要公司簡介

• Illumina
• Agilent Technologies
• Roche
• Danaher
• Abbott Laboratories
• Bio-Rad Laboratories
• Pacific Biosciences of California
• Quest Diagnostics
• PerkinElmer
• Luminex
• Myriad Genetics
• Qiagen
• Foundation Medicine
• Guardant Health
• Nanostring Technologies
• Oxford Nanopore Technologies
• Genomic Health
• Invitae
• 10x Genomics
• Natera

結論與建議

Global Genomics In Cancer Care Market size was valued at USD 21.06 Billion in 2024 and is poised to grow from USD 24.44 Billion in 2025 to USD 80.34 Billion by 2033, growing at a CAGR of 16.04% during the forecast period (2026-2033).

The Global Genomics in Cancer Care market is evolving with genomic profiling becoming essential in oncology. Technologies such as next-generation sequencing, bioinformatics platforms, and companion diagnostics are pivotal for identifying actionable mutations and personalizing therapies, leading to improved survival rates and minimized treatment toxicities. The transition from single-gene tests to multigene assays marks a significant progression, as reimbursement incentives increasingly motivate the adoption of molecular testing, which ultimately reduces costs linked to ineffective treatments. AI-driven genomics enhances this landscape by utilizing vast molecular datasets and machine learning to define treatment paths tailored to individual genetic profiles. This synergy of advanced technology and strategic investment attracts partnerships across biotech, pharma, and health IT, stimulating the growth and efficiency of personalized cancer care.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Genomics In Cancer Care market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Genomics In Cancer Care Market Segments Analysis

Global genomics in cancer care market is segmented by product and service, technology, application, cancer type and region. Based on product and service, the market is segmented into Instruments, Consumables and Services. Based on technology, the market is segmented into Next-Generation Sequencing, Polymerase Chain Reaction, Microarray and Others. Based on application, the market is segmented into Diagnostics, Personalized Medicine, Drug Discovery and Research. Based on cancer type, the market is segmented into Breast Cancer, Lung Cancer, Colorectal Cancer and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Genomics In Cancer Care Market

The growing integration of precision medicine within oncology is significantly enhancing the incorporation of genomic profiling into standard practices, allowing healthcare professionals to align treatments with the specific DNA signatures of individual tumors. This tailored approach not only leads to improved patient outcomes but also incentivizes healthcare providers to adopt advanced genomic technologies. As a result, pharmaceutical companies are encouraged to create targeted therapies, and payers increasingly acknowledge the long-term cost savings associated with sidestepping ineffective treatments. This momentum fosters a rising demand for comprehensive genomic sequencing services and associated data analytics, ultimately propelling the market forward.

Restraints in the Global Genomics In Cancer Care Market

The Global Genomics in Cancer Care market faces notable restraint due to regulatory complexities that vary across different regions. These complexities lead to inconsistent approval timelines, differing data privacy mandates, and diverse compliance standards for genomic assays, ultimately hindering market progress. Companies must maneuver through these unique regulatory environments, which can result in delays for product launches and heightened development costs. This situation may deter smaller enterprises from entering the market and create an atmosphere of uncertainty for potential investors. Additionally, the requirement for detailed documentation and continuous audits diverts valuable resources away from research and commercial initiatives, further stifling market expansion.

Market Trends of the Global Genomics In Cancer Care Market

The Global Genomics in Cancer Care market is witnessing a notable trend towards integrated clinical workflows, where the synergy between genomics laboratories, electronic health records, and oncology treatment platforms enhances the patient experience. This collaboration facilitates faster data exchange, significantly reducing turnaround times and allowing multidisciplinary teams to quickly address actionable mutations. Continuous monitoring of treatment responses further refines therapeutic decisions, contributing to better clinical outcomes and operational efficiency. As health systems increasingly recognize the importance of interoperability, there is a growing investment in infrastructure that effectively incorporates genomic insights into everyday cancer care, paving the way for innovative treatment approaches.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index 2025
• PESTEL Analysis
• Regulatory Landscape

Global Genomics In Cancer Care Market Size by Product and Service & CAGR (2026-2033)

• Market Overview
• Instruments
• Consumables
• Services

Global Genomics In Cancer Care Market Size by Technology & CAGR (2026-2033)

• Market Overview
• Next-Generation Sequencing
• Polymerase Chain Reaction
• Microarray
• Others

Global Genomics In Cancer Care Market Size by Application & CAGR (2026-2033)

• Market Overview
• Diagnostics
• Personalized Medicine
• Drug Discovery
• Research

Global Genomics In Cancer Care Market Size by Cancer Type & CAGR (2026-2033)

• Market Overview
• Breast Cancer
• Lung Cancer
• Colorectal Cancer
• Others

Global Genomics In Cancer Care Market Size & CAGR (2026-2033)

• North America (Product and Service, Technology, Application, Cancer Type)
  • US
  • Canada
• Europe (Product and Service, Technology, Application, Cancer Type)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product and Service, Technology, Application, Cancer Type)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product and Service, Technology, Application, Cancer Type)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product and Service, Technology, Application, Cancer Type)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Illumina
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agilent Technologies
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Roche
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pacific Biosciences of California
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Quest Diagnostics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PerkinElmer
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Luminex
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Myriad Genetics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Qiagen
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Foundation Medicine
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Guardant Health
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nanostring Technologies
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Oxford Nanopore Technologies
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Genomic Health
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Invitae
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• 10x Genomics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Natera
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations